|
| |
| | | 70389 | | 19.05.2026 | | Merck (Schweiz) AG | | | | | | | 18.05.2031 | | | | | | | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Ogsiveo 100 mg | Filmtabletten | Coated tablets (Nirogacestatum 100 mg) | L01XX81 | CI | | 02 | Ogsiveo 150 mg | Filmtabletten | Coated tablets (Nirogacestatum 150 mg) | L01XX81 | CI |
|
|
|
